November 20, 2017
EC approves Novartis’s Tasigna
The European Commission (EC) has approved Novartis’s Tasigna for the treatment of pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Tasigna